Lv2
128 积分 2022-05-11 加入
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial
3天前
已完结
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
5天前
已完结
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
5天前
已完结
Innovation in Alopecia Areata
10天前
已完结
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
1个月前
已完结
New Biological Treatment Options in CSU
2个月前
已完结
Rituximab in Refractory Chronic Spontaneous Urticaria: An Encouraging Therapeutic Approach
2个月前
已完结
Nemolizumab: First Approval
2个月前
已完结
Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling and Simulation
2个月前
已完结
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
2个月前
已关闭
皖公网安备34019202002308
